Psychedelics Investing

Compass Pathways to Participate in Stifel Virtual CNS Forum

Life Science Investing News

Avecho and Sandoz enter Exclusive License and Development Agreement to Commercialise CBD for Insomnia in Australia

SmartNews

Quantum Biopharma Announces Completion of the Phase 1 Multiple Ascending Dose Clinical Trial for its Experimental Multiple Sclerosis Drug Lucid-21-302

SmartNews

Compass Pathways to Participate in TD Cowen 45th Annual Health Care Conference

Life Science Investing News

Compass Pathways to announce fourth quarter and year-end financial results on February 27th, 2025

Life Science Investing News

Compass Pathways to announce fourth quarter and year-end financial results on February 27th, 2025

Life Science Investing News

Compass Pathways to announce fourth quarter and year-end financial results on February 27th, 2025

Life Science Investing News

Compass Pathways to announce fourth quarter and year-end financial results on February 27th, 2025

Life Science Investing News

Compass Pathways to announce fourth quarter and year-end financial results on February 27th, 2025

Life Science Investing News

Compass Pathways to announce fourth quarter and year-end financial results on February 27th, 2025

Life Science Investing News

Compass Pathways to announce fourth quarter and year-end financial results on February 27th, 2025

Life Science Investing News

Compass Pathways to announce fourth quarter and year-end financial results on February 27th, 2025

Life Science Investing News

Latest psychedelics News

More psychedelics News

Outlook Reports

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES
×